EN DE
STOCK COMPARISON

Entero Healthcare Solutions vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how Entero Healthcare Solutions (ENTERO) and McKesson (MCK) compare, as of Aug 13, 2026.

As of Aug 13, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Entero Healthcare Solutions trades at ₹1,420 versus a fair value of ₹582 (-59%), while McKesson trades at $902 versus $819 (-9%).
Entero Healthcare Solutions
ENTERO.NSE · INR · Health Care
-59%
upside to fair value
overvalued
Price₹1,420
Fair Value₹582
Quality45/100
McKesson
MCK · USD · Health Care
-9%
upside to fair value
fairly valued
Price$902
Fair Value$819
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Entero Healthcare SolutionsMcKesson
Valuation
44.6×P/E (TTM)21.0×
0.78×P/S (TTM)0.23×
3.04×P/B—
19.2×EV/EBITDA13.9×
—PEG1.57×
—Dividend yield0.4%
—Dividend per share$3.17
Profitability
2%Net margin1%
4%Operating margin2%
8%Return on equity—
4%Return on assets5%
Growth
43%Revenue growth (YoY)6%
25.9%Avg. growth/yr (3Y)13.4%
30.0%Avg. growth/yr (5Y)11.1%
Balance & size
0.07×Debt / equity—
$539MMarket cap$94B
expensiveGrowth qualityhealthy

Entero Healthcare Solutions leads: 5 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Entero Healthcare Solutionsof which business quality 45 · market factors 68 McKessonof which business quality 65 · market factors 66
ProfitabilityMargins and returns on capital today
41
49
Quality GrowthAre margins and returns improving?
56
65
CashflowEarnings quality: real cash, not paper profit
10
47
Fin. StrengthBalance sheet, leverage, solvency risk
59
72
InvestmentDisciplined investing over empire-building
33
76
Low VolatilityCalm price path (market factor)
75
83
MomentumPrice trend over the last 3–12 months (market factor)
59
52
52W MomentumDistance to the 52-week high (market factor)
77
69
Net IssuanceBuybacks instead of dilution
81
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Entero Healthcare Solutions

DCF Models₹799
Earnings-Based₹774
Multiples₹628
Asset-Based₹260
Growth DCF₹21.06
Economic Profit₹486
Growth Earnings₹972

23 of 23 models see the stock below the current price.

McKesson

DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708

15 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Entero Healthcare Solutions
Bear ₹335Fair Value ₹582Bull ₹727
₹1,420 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$902 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Entero Healthcare Solutions · Health Care

Quality score45 · below median
Fair value upside-59% · below median

McKesson · Health Care

Quality score66 · Top 25%
Fair value upside-9% · above median

Bottom line

As of Aug 13, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Entero Healthcare Solutions trades at ₹1,420 versus a fair value of ₹582 (-59%), while McKesson trades at $902 versus $819 (-9%).

McKesson has the higher quality score (66/100).

See the full analysis →
Entero Healthcare Solutions · McKesson

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Entero Healthcare Solutions

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to McKesson

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.